Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...
2d
Hosted on MSNHere's Why Illumina (ILMN) is a Strong Growth StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
StockStory.org on MSN4d
Why Illumina (ILMN) Stock Is Trading Lower TodayWhat Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...
CEO Dr. Reshma Kewalramani said Journavx was "the first new class of pain medicine approved in more than 20 years," adding that the treatment provides "the opportunity to change the paradigm of ...
But this stock price swing has nothing to do with sales. Instead, it likely has to do with Walgreens’ changes to its dividend payouts. Here’s what you need to know. As of the time of this ...
Shareholder activism continued at a record pace in 2024 as activist hedge funds pushed for strategic changes […] Macrogen a global healthcare company that specializes in precision medicine and ...
Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for ...
Shares of Illumina Inc. ILMN slid 3.22% to $133.61 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.92% to 6,067.70 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results